161 related articles for article (PubMed ID: 33438855)
41. Clinical efficacy of Lactobacillus reuteri-containing lozenges in the supportive therapy of generalized periodontitis stage III and IV, grade C: 1-year results of a double-blind randomized placebo-controlled pilot study.
Grusovin MG; Bossini S; Calza S; Cappa V; Garzetti G; Scotti E; Gherlone EF; Mensi M
Clin Oral Investig; 2020 Jun; 24(6):2015-2024. PubMed ID: 31620939
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of an Oral Rehydration Solution Enriched with
Maragkoudaki M; Chouliaras G; Moutafi A; Thomas A; Orfanakou A; Papadopoulou A
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30200394
[TBL] [Abstract][Full Text] [Related]
43. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial.
Jørgensen MR; Keller MK; Kragelund C; Hamberg K; Ericson D; Nielsen CH; Twetman S
Acta Odontol Scand; 2016 Jul; 74(5):399-404. PubMed ID: 27104984
[TBL] [Abstract][Full Text] [Related]
44. Probiotics for the Management of Infantile Colic: A Systematic Review.
Simonson J; Haglund K; Weber E; Fial A; Hanson L
MCN Am J Matern Child Nurs; 2021 Mar-Apr 01; 46(2):88-96. PubMed ID: 33315632
[TBL] [Abstract][Full Text] [Related]
45. Lactobacillus Reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial.
Oncel MY; Sari FN; Arayici S; Guzoglu N; Erdeve O; Uras N; Oguz SS; Dilmen U
Arch Dis Child Fetal Neonatal Ed; 2014 Mar; 99(2):F110-5. PubMed ID: 24309022
[TBL] [Abstract][Full Text] [Related]
46. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial.
Ojetti V; Ianiro G; Tortora A; D'Angelo G; Di Rienzo TA; Bibbò S; Migneco A; Gasbarrini A
J Gastrointestin Liver Dis; 2014 Dec; 23(4):387-91. PubMed ID: 25531996
[TBL] [Abstract][Full Text] [Related]
47. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.
Mobini R; Tremaroli V; Ståhlman M; Karlsson F; Levin M; Ljungberg M; Sohlin M; Bertéus Forslund H; Perkins R; Bäckhed F; Jansson PA
Diabetes Obes Metab; 2017 Apr; 19(4):579-589. PubMed ID: 28009106
[TBL] [Abstract][Full Text] [Related]
48. Evidence of Lactobacillus reuteri to reduce colic in breastfed babies: Systematic review and meta-analysis.
Dos Reis Buzzo Zermiani AP; de Paula Soares ALPP; da Silva Guedes de Moura BL; Miguel ERA; Lopes LDG; de Carvalho Scharf Santana N; da Silva Santos T; Demarchi IG; Teixeira JJ
Complement Ther Med; 2021 Dec; 63():102781. PubMed ID: 34627993
[TBL] [Abstract][Full Text] [Related]
49. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea--a double-blind study.
Francavilla R; Lionetti E; Castellaneta S; Ciruzzi F; Indrio F; Masciale A; Fontana C; La Rosa MM; Cavallo L; Francavilla A
Aliment Pharmacol Ther; 2012 Aug; 36(4):363-9. PubMed ID: 22680836
[TBL] [Abstract][Full Text] [Related]
50. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
51. Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study.
Francavilla R; Polimeno L; Demichina A; Maurogiovanni G; Principi B; Scaccianoce G; Ierardi E; Russo F; Riezzo G; Di Leo A; Cavallo L; Francavilla A; Versalovic J
J Clin Gastroenterol; 2014; 48(5):407-13. PubMed ID: 24296423
[TBL] [Abstract][Full Text] [Related]
52. Effectiveness of Lactobacillus reuteri DSM 17938 for the Prevention of Nosocomial Diarrhea in Children: A Randomized, Double-blind, Placebo-controlled Trial.
Urbańska M; Gieruszczak-Białek D; Szymański H; Szajewska H
Pediatr Infect Dis J; 2016 Feb; 35(2):142-5. PubMed ID: 26551445
[TBL] [Abstract][Full Text] [Related]
53. Lactobacillus reuteri (DSM 17938) in infants with functional chronic constipation: a double-blind, randomized, placebo-controlled study.
Coccorullo P; Strisciuglio C; Martinelli M; Miele E; Greco L; Staiano A
J Pediatr; 2010 Oct; 157(4):598-602. PubMed ID: 20542295
[TBL] [Abstract][Full Text] [Related]
54. The effectiveness of Lactobacillus reuteri DSM 17938 as an adjunct to macrogol in the treatment of functional constipation in children. A randomized, double-blind, placebo-controlled, multicentre trial.
Wegner A; Banaszkiewicz A; Kierkus J; Landowski P; Korlatowicz-Bilar A; Wiecek S; Kwiecien J; Gawronska A; Dembinski L; Czaja-Bulsa G; Socha P
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):494-500. PubMed ID: 29650440
[TBL] [Abstract][Full Text] [Related]
55. Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight infants.
Oncel MY; Arayici S; Sari FN; Simsek GK; Yurttutan S; Erdeve O; Saygan S; Uras N; Oguz SS; Dilmen U
J Matern Fetal Neonatal Med; 2015; 28(15):1790-4. PubMed ID: 25245226
[TBL] [Abstract][Full Text] [Related]
56. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life.
Abrahamsson TR; Sinkiewicz G; Jakobsson T; Fredrikson M; Björkstén B
J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):349-54. PubMed ID: 19525871
[TBL] [Abstract][Full Text] [Related]
57. Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial.
Ismail NI; Nawawi KNM; Hsin DCC; Hao KW; Mahmood NRKN; Chearn GLC; Wong Z; Tamil AM; Joseph H; Raja Ali RA
Helicobacter; 2023 Dec; 28(6):e13017. PubMed ID: 37614081
[TBL] [Abstract][Full Text] [Related]
58. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
[TBL] [Abstract][Full Text] [Related]
59. Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
del Campo R; Garriga M; Pérez-Aragón A; Guallarte P; Lamas A; Máiz L; Bayón C; Roy G; Cantón R; Zamora J; Baquero F; Suárez L
J Cyst Fibros; 2014 Dec; 13(6):716-22. PubMed ID: 24636808
[TBL] [Abstract][Full Text] [Related]
60. Infant Colic-What works: A Systematic Review of Interventions for Breast-fed Infants.
Harb T; Matsuyama M; David M; Hill RJ
J Pediatr Gastroenterol Nutr; 2016 May; 62(5):668-86. PubMed ID: 26655941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
